Malin Pedersen
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Immunology top 5%
- Immunotherapy and Immune Responses
- interferon and immune responses
Papers in
-
- Melanoma and MAPK Pathways 6
- PI3K/AKT/mTOR signaling in cancer 4
- Cell death mechanisms and regulation 3
- Oncology 14
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Kevin J. Harrington (15 shared papers)Martin McLaughlin (11 shared papers)Magnus T. Dillon (7 shared papers)Alan Melcher (11 shared papers)Emmanuel C. Patin (8 shared papers)Anna Wilkins (3 shared papers)Richard Marais (13 shared papers)Lars Rönnstrand (7 shared papers)
- Journals
- Cancer Research (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)Cancer Discovery (3 papers)Frontiers in Oncology (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Malin Pedersen
36 papers receiving 2.4k citations
Malin Pedersen's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 962
- Immunology 629
- Ophthalmology 162
- Cancer Research 260
- Molecular Biology 1.2k
Countries citing papers authored by Malin Pedersen
This map shows the geographic impact of Malin Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malin Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malin Pedersen more than expected).
Fields of papers citing papers by Malin Pedersen
This network shows the impact of papers produced by Malin Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malin Pedersen. The network helps show where Malin Pedersen may publish in the future.
Co-authors
The 25 scholars most cited alongside Malin Pedersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inflammatory microenvironment remodelling by tumour cells after radiotherapy Hit paper breakdown → | 2020 | 633 |
| 2 | SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma Hit paper breakdown → | 2013 | 333 |
| 3 | 2012 | 276 | |
| 4 | 2014 | 177 | |
| 5 | 2019 | 152 | |
| 6 | 2014 | 107 | |
| 7 | 2016 | 87 | |
| 8 | 2008 | 62 | |
| 9 | 2009 | 60 | |
| 10 | 2006 | 57 | |
| 11 | 2015 | 56 | |
| 12 | 2013 | 55 | |
| 13 | 2020 | 54 | |
| 14 | 2008 | 49 | |
| 15 | 2018 | 41 | |
| 16 | 2015 | 38 | |
| 17 | 2007 | 36 | |
| 18 | 2017 | 32 | |
| 19 | 2022 | 27 | |
| 20 | 2020 | 27 |
About Malin Pedersen
Malin Pedersen is a scholar working on Molecular Biology, Oncology, Immunology, Genetics and Dermatology, having authored 39 papers that have together received 2.5k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Virus-based gene therapy research (5 papers), interferon and immune responses (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Cell death mechanisms and regulation (3 papers), Skin Protection and Aging (3 papers) and Mast cells and histamine (3 papers). The work is most often cited by research in Oncology (962 citations), Immunology (629 citations), Ophthalmology (162 citations), Cancer Research (260 citations) and Molecular Biology (1.2k citations). Malin Pedersen has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Kevin J. Harrington, Martin McLaughlin, Magnus T. Dillon, Alan Melcher, Emmanuel C. Patin, Anna Wilkins, Richard Marais, Lars Rönnstrand, Jianmin Sun and Samra Turajlic. Their work appears in journals such as Cancer Research, Journal for ImmunoTherapy of Cancer, Cancer Discovery, Frontiers in Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.